Baker Bros. Advisors’s Immunomedics Inc IMMU Stock Holding History

Baker Bros. Advisors’s Portfolio IMMU Stock Details IMMU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-237,694	Closed	-$20.2M	–	133
2020 Q3	$20.2M	Sell	237,694 -92,306	-28%	-$4.67M	0.08%	54
2020 Q2	$11.7M	Buy	330,000 +20,000	+6%	+$585K	0.05%	54
2020 Q1	$4.18M	Buy	+310,000	New	+$5.22M	0.03%	70

Baker Bros. Advisors's IMMU Position: Q4 2020 in Review

Baker Bros. Advisors sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 237,694 shares — an estimated $20.2M sold.

Baker Bros. Advisors first reported a position in IMMU in Q1 2020 and held it in 3 quarters. The position peaked at $20.2M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

Baker Bros. Advisors reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
Baker Bros. Advisors sold 237,694 Immunomedics Inc shares in Q4 2020, an estimated $20.2M.
Baker Bros. Advisors first reported a position in Immunomedics Inc in Q1 2020 and held it in 3 quarters.
Baker Bros. Advisors's Immunomedics Inc position peaked at $20.2M in Q3 2020.
0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Baker Bros. Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.